0001062993-23-010091.txt : 20230503
0001062993-23-010091.hdr.sgml : 20230503
20230503162046
ACCESSION NUMBER: 0001062993-23-010091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doyle John Brendan
CENTRAL INDEX KEY: 0001840738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40886
FILM NUMBER: 23884323
MAIL ADDRESS:
STREET 1: C/O CHIASMA INC.
STREET 2: 140 KENDRICK STREET BUILDING C EAST
CITY: NEEDHAM
STATE: MA
ZIP: 20494
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001455365
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2403 SIDNEY STREET
STREET 2: SUITE 261
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: 412-481-2210
MAIL ADDRESS:
STREET 1: 2500 WESTCHESTER AVE
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: COGNITION THERAPUTICS INC
DATE OF NAME CHANGE: 20090204
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-05-01
0001455365
COGNITION THERAPEUTICS INC
CGTX
0001840738
Doyle John Brendan
C/O COGNITION THERAPEUTICS, INC.
2500 WESTCHESTER AVE
PURCHASE
NY
10577
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-05-01
4
A
0
109824
0.00
A
109824
D
Stock Option (right to buy)
1.65
2023-05-01
4
A
0
109824
0.00
A
2033-05-01
Common Stock
109824
109824
D
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.
/s/ Lisa Ricciardi, Attorney-in-Fact
2023-05-03